International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7899713
Original Article
Spectrum of Direct Maternal Deaths: An Autopsy Study in a Tertiary Care Hospital
 ,
 ,
 ,
Published
May 30, 2023
Abstract
BACKGROUND: - Maternal deaths have always been a challenge worldwide. Autopsy based study in cases of maternal mortality serves as an indispensable tool to analyse causes of maternal mortality. AIMS: - To study incidence of varying direct causes of maternal deaths. To study the precedent risk factors and analysis of direct causes of maternal deaths with variables like age, trimester of pregnancy, gravidity, duration of hospital stays, etc. To compare clinical diagnosis with autopsy diagnosis. DESIGN: This study is retrospective observational study over 6 years and 1 year of prospective observational study in the department of Pathology at a tertiary care centre. MATERIALS AND METHODS: - Autopsy records of 75 maternal mortality cases where pathology autopsy was performed in this period were studied. The available gross specimens and histopathology slides were retrieved and studied. RESULTS: - Most common direct cause of maternal death in this study was found to be peripartum dilated cardiomyopathy (26.65%), followed by DIC (14.6%). Maternal deaths were found to be more prevalent in age group 21-25 years (32.42%), multigravida & multiparous. Most of the maternal deaths were in postpartum period (57.76%) and in third trimester (6.46%) if antepartum, with vaginal mode of delivery. Hospital stay was between 24 hours to 1 week. CONCLUSION: -Peripartum dilated cardiomyopathy was most common frequent maternal death in this study. Since the most frequent etiologies that lead to maternal death are preventable, more autopsy studies can be of great help in eliminating these.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2349 Views
2 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved